 After the discovery of HIV protease it only took 10 years for its first inhibitor to reach the market.The first reports of highly selective antagonists against the HIV protease were revealed in 1987.Phase I trials of saquinavir began in 1989 and it was the first HIV protease inhibitor to be approved for prescription use in 1995.